Kyverna Therapeutics, Inc. Share Price
NASDAQ: KYTX | Micro CapKyverna Therapeutics, Inc. Stock Performance
Kyverna Therapeutics, Inc. Share Price Today
As of 30 October 2026, Kyverna Therapeutics, Inc.'s share price is $5.84. The stock opened at $6.11, compared to its previous close of $5.88. During today's trading session, Kyverna Therapeutics, Inc.'s share price traded between $5.84 and $6.11, with an average price of $5.97. Over the past 52 weeks, the stock has recorded a high of $13.60 and a low of $5.17. In terms of performance, Kyverna Therapeutics, Inc.'s share price has declined by 33.81% over the last six months and is down 16.02% on a year-on-year basis.
Kyverna Therapeutics, Inc. Share Price Chart
Kyverna Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Kyverna Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Kyverna Therapeutics, Inc.
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
Kyverna Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $6.74 | $5.86 | -14.14% |
Sep 2026 | $8.28 | $6.83 | -20.96% |
Aug 2026 | $7.30 | $8.63 | +18.29% |
Jul 2026 | $8.91 | $7.30 | -17.98% |
Jun 2026 | $8.46 | $8.90 | +4.64% |
May 2026 | $8.77 | $8.51 | -3.68% |
Apr 2026 | $8.66 | $8.83 | +2.08% |
Mar 2026 | $7.88 | $8.65 | +5.23% |
Feb 2026 | $7.91 | $8.22 | +2.62% |
Jan 2026 | $9.46 | $8.01 | -14.61% |
Dec 2025 | $7.38 | $9.38 | +21.82% |
Nov 2025 | $6.98 | $7.70 | +10.63% |